DOI: 10.1111/dom.13038 , , PMID: 28608617 Issn Print: 1462-8902 Publication Date: 2018/01/01 Print Facebook Twitter LinkedIn Email Long‐term safety and efficacy of canagliflozin as add‐on therapy to teneligliptin in Japanese patients with type 2 diabetes Takashi Kadowaki; Nobuya Inagaki; Kazuoki Kondo; Kenichi Nishimura; Genki Kaneko; Nobuko Maruyama; Nobuhiro Nakanishi; Yumi Watanabe; Maki Gouda; Hiroaki Iijima + Author Information Author Information: Department of Diabetes and Metabolic Diseases Checking for direct PDF access through Ovid View on Journal Site Abstract Abstract unavailable for this article.
Facebook
Twitter
LinkedIn
Email
